The Panel has received an application from Villefranche Investments Pty Limited as trustee of the Gates Family Trust seeking a review of the Panel’s decision in A S P Aluminium Holdings Pty Ltd (see TP23/21).
The Panel has declined to make a declaration of unacceptable circumstances in response to an application dated 2 May 2023 from Villefranche Investments Pty Limited as trustee of the Gates Family Trust in relation to the affairs of A S P Aluminium Holdings Pty Ltd (see TP23/17).
The Panel considered (among other matters) that:
The Panel has made a declaration of unacceptable circumstances (Annexure A) in relation to an application dated 6 February 2023 by UIL Limited in relation to the affairs of The Market Herald Limited (see TP23/08).
The Market Herald Limited (TMH) is an ASX listed company (ASX code: TMH) formerly known as HotCopper Holdings Limited.
The Panel has made interim orders in response to an application for interim orders dated 2 May 2023 by Villefranche Investments Pty Limited as trustee of the Gates Family Trust in relation to the affairs of A S P Aluminium Holdings Pty Ltd (ASP).
The interim orders state (in summary) that:
The Panel refers to its media release dated 2 May 2023 (see TP23/016).
The Panel has received an application from Villefranche Investments Pty Limited as trustee of the Gates Family Trust (the Applicant) in relation to the affairs of A S P Aluminium Holdings Pty Ltd (ASP).
Details of the application, as submitted by the Applicant, are below.
A sitting Panel has not been appointed at this stage and no decision has been made whether to conduct proceedings. The Panel makes no comment on the merits of the application.
The Panel has made an application to the Federal Court, seeking an order under section 657B of the Corporations Act 2001 (Cth) for the time that a Panel may make a declaration of unacceptable circumstances in relation to the affairs of The Market Herald Limited to be extended to 19 May 2023.
The First Case Management Hearing in relation to the Federal Court application is scheduled for 9.30am Friday, 5 May 2023 in Melbourne.
The Panel has declined to conduct proceedings on an application dated 28 March 2023 from Healius Limited (Healius) in relation to its affairs.
Healius is currently the subject of an off‑market scrip takeover bid made by Australian Clinical Labs Limited (ACL) and the application primarily concerned the contents of the Bidder’s Statement lodged in connection with the bid (see TP23/013).